ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2613

Positive Spine MRI for Inflammation Predicts Radiographic Progression in Patients with Ankylosing Spondylitis

Walter P. Maksymowych1, S Wichuk2, Z Zhao3, P Chiowchanwisawakit4, RG Lambert5 and Sj Pedersen6, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3PLA General Hospital, Beijing, China, 4Mahidol University, Bangkok, Thailand, 5Radiology, University of Alberta, Edmonton, AB, Canada, 6Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), Magnetic resonance imaging (MRI), prognostic factors and radiography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose: Inflammation at vertebral corners on MRI has been shown to predict development of syndesmophytes in patients with AS. However, it is unclear at a patient level whether a positive spine MRI for inflammation identifies patients at higher risk for radiographic progression and whether this is also associated with the degree of spinal inflammation. We used the SPARCC MRI spine score to assess whether the proposed cut-off of ≥2 for positive spine MRI and the absolute score are predictive of radiographic progression.

Methods: Spinal inflammation was scored blinded to time point (baseline, 2 years) using the SPARCC spine score by two readers and an adjudicator using pre-specified rules for adjudication. MRI scans were assessed from a prospective cohort of 195 AS patients (mean age 40.3 years, mean symptom duration 16.6 years, 59% on anti-TNF) followed for mean 2.3 years. Two readers and an adjudicator independently scored pairs of radiographs (baseline, 2 years) from the same patients using the mSASSS.  Radiographic progression was compared in patients with and without positive spine MRI (SPARCC ≥2 or <2) and the degree of spinal inflammation at baseline (absolute SPARCC score) was compared in patients with and without radiographic progression (mSASSS >0 or =0) using Mann-Whitney and cumulative probability. Multivariate regression analyses included variables significant in univariate analyses (age, sex, symptom duration, CRP, baseline mSASSS) and treatment.

Results: Radiographic progression was significantly greater in those with positive spine MRI (p=0.004) (figure), and especially in patients who only received non-biologic therapy (p=0.006). Baseline SPARCC spine inflammation scores were significantly higher in those who developed radiographic progression compared to those without (14.5 vs 8.7, p=0.002). Positive spine MRI and the degree of spinal inflammation score were both significantly associated with radiographic progression in multivariate analysis (β=0.26 (p=0.019) and β=0.006 (p=0.036), respectively).

 

Conclusion: Both a positive spine MRI for inflammation and the degree of spinal inflammation are significantly associated with radiographic progression in patients with AS.

 


Disclosure:

W. P. Maksymowych,
None;

S. Wichuk,
None;

Z. Zhao,
None;

P. Chiowchanwisawakit,
None;

R. Lambert,
None;

S. Pedersen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/positive-spine-mri-for-inflammation-predicts-radiographic-progression-in-patients-with-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology